AstraZeneca and Absci partnership paves the way for AI-generated cancer antibodies, potentially eliminating the need for chemotherapy

AstraZeneca and Absci have signed a deal worth $247 million to collaborate on developing cancer antibodies using generative AI, reports Reuters. AstraZeneca aims to replace chemotherapy and sees this partnership as a significant step towards achieving that goal. They plan to use Absci’s AI technology for large-scale protein analysis to search for a workable cancer […]

Continue Reading

“Doc.com: Revolutionizing Medicine Access with an Innovative Healthcare Solution”

Doc.com, founded by Charles Nader, is a digital healthcare service that aims to revolutionize the accessibility of healthcare. The CEO, Charles Nader, envisions a future where healthcare is a right for everyone, rather than a privilege for the few. The app offers technological benefits such as precise diagnosis, blockchain rewards, and statistical public health analytics. […]

Continue Reading